C. Owen

415 total citations
9 papers, 76 citations indexed

About

C. Owen is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Owen has authored 9 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Owen's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). C. Owen is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). C. Owen collaborates with scholars based in United Kingdom, Australia and United States. C. Owen's co-authors include Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long, Ismael A. Vergara, Richard A. Scolyer, Andrew J. Colebatch, Leonard W. Seymour, Umaimainthan Palendira, Tasnia Ahmed and Daniel JB Marks and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gene Therapy.

In The Last Decade

C. Owen

9 papers receiving 75 citations

Peers

C. Owen

ONCOL

IMMUN

MB

SURGE

CCM

Tania Baccega Italy

Foysal Daian United States

Suzana Matković Serbia

Adrien Procureur France

Jaromír Háček Czechia

Matthew Pergamo United States

Athanassios Vratimos Greece

Santiago Sánchez‐Alonso Spain

Yaacov Samet Israel

Kate Wilkinson Australia

Tania Baccega Italy

C. Owen

27 ×0.6

ONCOL

63 ×2.2

IMMUN

36 ×1.8

MB

16 ×0.9

SURGE

3 ×0.4

CCM

Citations per year, relative to C. Owen C. Owen (= 1×) peers Tania Baccega

Countries citing papers authored by C. Owen

Since Specialization

Citations

This map shows the geographic impact of C. Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Owen more than expected).

Fields of papers citing papers by C. Owen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Owen. The network helps show where C. Owen may publish in the future.

Co-authorship network of co-authors of C. Owen

This figure shows the co-authorship network connecting the top 25 collaborators of C. Owen. A scholar is included among the top collaborators of C. Owen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Owen. C. Owen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Schreiber, S, Aoife Keohane, Baojin Zhu, et al.. (2025). P1071 Trajectories of response in patients with moderately-to-severely active ulcerative colitis treated with mirikizumab: Results from the LUCENT-1 study. Journal of Crohn s and Colitis. 19(Supplement_1). i1975–i1976. 1 indexed citations

2.

Owen, C., Sarah Cook, Richard A. Squires, et al.. (2023). 422P UK real-world data (RWD) of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) use in metastatic breast cancer (MBC). Annals of Oncology. 34. S360–S360. 1 indexed citations

3.

Attrill, Grace H., C. Owen, Tasnia Ahmed, et al.. (2022). Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy. Journal for ImmunoTherapy of Cancer. 10(6). e004771–e004771. 31 indexed citations

4.

Owen, C., Xue Bai, Thuan Chong Quah, et al.. (2020). 1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy. Annals of Oncology. 31. S761–S762. 2 indexed citations

5.

Owen, C., James Larkin, Alexander N. Shoushtari, et al.. (2019). A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.. Journal of Clinical Oncology. 37(15_suppl). 9502–9502. 8 indexed citations

6.

Owen, C., Anastasia Constantinidou, Aisha Miah, et al.. (2018). Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management. Anticancer Research. 38(9). 5275–5282. 5 indexed citations

7.

Owen, C., et al.. (2018). Management of melanoma recurrence following adjuvant anti-PD1 therapy. Annals of Oncology. 29. viii446–viii447. 2 indexed citations

8.

Owen, C., et al.. (2014). The dangers of proton pump inhibitor therapy. British Journal of Hospital Medicine. 75(Sup7). C108–C112. 9 indexed citations

9.

Hibbitt, Olivia, C. Owen, Milena Cioroch, et al.. (2011). RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo. Gene Therapy. 19(4). 463–467. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact